Cargando…
Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion
BACKGROUND: Tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) may occasionally show similar cytological and biochemical picture including ADA. In such cases, differentiating TPE and MPE is challenging and needs histopathology of pleural tissue which may involve invasive procedu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504718/ https://www.ncbi.nlm.nih.gov/pubmed/37715196 http://dx.doi.org/10.1186/s12890-023-02644-9 |
_version_ | 1785106787272228864 |
---|---|
author | Rabbi, Mohammad Fazle Ahmed, Mushfiq Newaz Patowary, Md. Shafiqul Alam Huq, Syed Rezaul Razzaque, S. M. Abdur Arafat, Hossain Md. Nahar, Tasnuva Iktidar, Mohammad Azmain |
author_facet | Rabbi, Mohammad Fazle Ahmed, Mushfiq Newaz Patowary, Md. Shafiqul Alam Huq, Syed Rezaul Razzaque, S. M. Abdur Arafat, Hossain Md. Nahar, Tasnuva Iktidar, Mohammad Azmain |
author_sort | Rabbi, Mohammad Fazle |
collection | PubMed |
description | BACKGROUND: Tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) may occasionally show similar cytological and biochemical picture including ADA. In such cases, differentiating TPE and MPE is challenging and needs histopathology of pleural tissue which may involve invasive procedures. The present study aims to evaluate the diagnostic accuracy of pleural fluid ADA to serum CRP (ADA/CRP) ratio to discriminate between tuberculous and malignant pleural effusion. In addition, we investigated whether the ratio ADA/CRP adds diagnostic value to ADA. METHODS: This cross-sectional study was conducted in the National Institute of Diseases of the Chest and Hospital (NIDCH), Mohakhali, Dhaka, from July 2021 to February 2022 on diagnosed patients of TPE and malignant pleural effusion MPE. A receiver operating characteristic curve (ROC) was constructed for identifying TPE. The added value of the ADA/CRP ratio to ADA was evaluated using the net reclassification improvement (NRI) and integrated discrimination improvement (IDI). A value of p < 0.05 was considered statistically significant for all tests. RESULTS: Fifty-nine patients were enrolled in this study, of which 31 had TPE, and 28 had MPE. Pleural fluid ADA to serum CRP ratio and pleural fluid ADA level was significantly higher in patients with TPE, but there was no significant difference in serum CRP levels between patients with TPE and MPE. At cut off value of > 1.25, pleural fluid ADA to serum CRP ratio had a sensitivity of 93.8%, specificity of 85.2%, and positive and negative predictive values were 88.2% and 92% respectively, in the diagnosis of TPE and area under ROC curve (AUC) was 0.94. The NRI and IDI analyses revealed added diagnostic value of ADA/CRP to ADA. CONCLUSION: This study shows that the ADA/CRP ratio improves the diagnostic usefulness of ADA for TPE. |
format | Online Article Text |
id | pubmed-10504718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105047182023-09-17 Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion Rabbi, Mohammad Fazle Ahmed, Mushfiq Newaz Patowary, Md. Shafiqul Alam Huq, Syed Rezaul Razzaque, S. M. Abdur Arafat, Hossain Md. Nahar, Tasnuva Iktidar, Mohammad Azmain BMC Pulm Med Research BACKGROUND: Tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE) may occasionally show similar cytological and biochemical picture including ADA. In such cases, differentiating TPE and MPE is challenging and needs histopathology of pleural tissue which may involve invasive procedures. The present study aims to evaluate the diagnostic accuracy of pleural fluid ADA to serum CRP (ADA/CRP) ratio to discriminate between tuberculous and malignant pleural effusion. In addition, we investigated whether the ratio ADA/CRP adds diagnostic value to ADA. METHODS: This cross-sectional study was conducted in the National Institute of Diseases of the Chest and Hospital (NIDCH), Mohakhali, Dhaka, from July 2021 to February 2022 on diagnosed patients of TPE and malignant pleural effusion MPE. A receiver operating characteristic curve (ROC) was constructed for identifying TPE. The added value of the ADA/CRP ratio to ADA was evaluated using the net reclassification improvement (NRI) and integrated discrimination improvement (IDI). A value of p < 0.05 was considered statistically significant for all tests. RESULTS: Fifty-nine patients were enrolled in this study, of which 31 had TPE, and 28 had MPE. Pleural fluid ADA to serum CRP ratio and pleural fluid ADA level was significantly higher in patients with TPE, but there was no significant difference in serum CRP levels between patients with TPE and MPE. At cut off value of > 1.25, pleural fluid ADA to serum CRP ratio had a sensitivity of 93.8%, specificity of 85.2%, and positive and negative predictive values were 88.2% and 92% respectively, in the diagnosis of TPE and area under ROC curve (AUC) was 0.94. The NRI and IDI analyses revealed added diagnostic value of ADA/CRP to ADA. CONCLUSION: This study shows that the ADA/CRP ratio improves the diagnostic usefulness of ADA for TPE. BioMed Central 2023-09-15 /pmc/articles/PMC10504718/ /pubmed/37715196 http://dx.doi.org/10.1186/s12890-023-02644-9 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Rabbi, Mohammad Fazle Ahmed, Mushfiq Newaz Patowary, Md. Shafiqul Alam Huq, Syed Rezaul Razzaque, S. M. Abdur Arafat, Hossain Md. Nahar, Tasnuva Iktidar, Mohammad Azmain Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion |
title | Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion |
title_full | Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion |
title_fullStr | Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion |
title_full_unstemmed | Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion |
title_short | Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion |
title_sort | pleural fluid adenosine deaminase to serum c-reactive protein ratio for diagnosing tuberculous pleural effusion |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504718/ https://www.ncbi.nlm.nih.gov/pubmed/37715196 http://dx.doi.org/10.1186/s12890-023-02644-9 |
work_keys_str_mv | AT rabbimohammadfazle pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT ahmedmushfiqnewaz pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT patowarymdshafiqulalam pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT huqsyedrezaul pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT razzaquesmabdur pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT arafathossainmd pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT nahartasnuva pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion AT iktidarmohammadazmain pleuralfluidadenosinedeaminasetoserumcreactiveproteinratiofordiagnosingtuberculouspleuraleffusion |